Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection

New England Journal of Medicine

Volumn 324, Issue 3, 1991, Pages 137-144

  Butler, Karina M ^a   Husson, Robert N ^a   Balis, Frank M ^a   Brouwers, Pim ^a   Eddy, Janie ^a   El Amin, Deborah ^b   Gress, Janet ^a   Hawkins, Mary ^a   Jarosinski, Paul ^c   Moss, Howard ^b   Poplack, David ^a   Santacroce, Sheila ^a   Venzon, David ^a   Wiener, Lori ^a   Wolters, Pamela ^b   Philip, A Pizzo ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Medical Illness Counseling Center   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BIOAVAILABILITY; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOXICITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MALE; ORAL DRUG ADMINISTRATION; PANCREATITIS; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0026017151     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199101173240301     Document Type: Article

References (20)

1. Pizzo P.A., Eddy J., Falloon J., et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 1988; 319:889-896
2. Fischl M.A., Richman D.D., Grieco M.H., et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987; 317:185-191
3. McKinney R.E. Jr., Pizzo P.A., Scott G.B., et al. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus–infected pediatric patients. J Pediatr 1990; 116:640-647
4. Blanche S., Caniglia M., Fischer A., et al. Zidovudine therapy in children with acquired immunodeficiency syndrome. Am J Med 1988; 85:Suppl 2A:203-207
5. Dournon E., Matheron S., Rozenbaum W., et al. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet 1988; 2:1297-1302
6. Richman D.D., Fischl M.A., Grieco M.H., et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987; 317:192-197
7. Fischl M.A., Richman D.D., Causey D.M., et al. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. JAMA 1989; 262:2405-2410
8. Mitsuya H., Broder S. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc Natl Acad Sci USA 1986; 83:1911-1915
9. Cooney D.A., Ahluwalia G., Mitsuya H., et al. Initial studies on the cellular pharmacology of 2′,3′-dideoxyadenosine, an inhibitor of HTLV-III infectivity. Biochem Pharmacol 1987; 36:1765-1768
10. Yarchoan R., Mitsuya H., Myers C.E., Broder S. Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. N Engl J Med 1989; 321:726-738
11. Yarchoan R., Mitsuya H., Thomas R.V., et al. In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine. Science 1989; 245:412-415
12. Lambert J.S., Seidlin M., Reichman R.C., et al. 2′,3′-Dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or the AIDS-related complex: a Phase I trial. N Engl J Med 1990; 322:1333-1340
13. Cooley T.P., Kunches L.M., Saunders C.A., et al. Once-daily administration of 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: results of a Phase I trial. N Engl J Med 1990; 322:1340-1345
14. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1987; 36:225-236
15. Brouwers P., Moss H., Wolters P., et al. Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. J Pediatr 1990; 117:980-985
16. Carpen M.E., Poplack D.G., Pizzo P.A., Balis F.M. High performance liquid Chromatographic method for analysis of 2′,3′-dideoxyinosine in human body fluids. J Chromatogr 1990; 526:69-75.
17. Hart C.C. Aerosolized pentamidine and pancreatitis. Ann Intern Med 1989; 111:691.
18. Murphy R.L., Noskin G.A., Ehrenpreis E.D. Acute pancreatitis associated with aerosolized pentamidine. Am J Med 1990; 88:53N-56N.
19. Fischl M.A., Richman D.T., Hansen N., et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind, placebo-controlled trial. Ann Intern Med 1990; 112:727-737
20. Yanase Y., Tango T., Okumura K., Tada T., Kawasaki T. Lymphocyte subsets identified by monoclonal antibodies in healthy children. Pediatr Res 1986; 20:1147-1151